This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
AML - 525
Acute Myeloid Leukemia (AML)
Measurable Residual Disease-Guided Therapeutic Strategies and Survival Outcomes in Hematologic Malignancies
A Systematic Review and Meta-Analysis of Leukemia and Lymphoma Trials
Nuri Tamanna, MD1 , MD Abu Bakar Siddique2 , Anid Hassan, MD3
1- SUNY Upstate Medical University, Syracuse, NY • 2- Department of Biological Sciences, St. John's University, New York, NY • 3- Hackensack Meridian Jersey Shore University Medical Center, NJ
PROSPERO registration: CRD420261402586